We had a great time at the Bradfield Centre, Cambridge Science Park at our BioWednesday on 1 February in collaboration with Appleyard Lees IP LLP discussing 'How do Investors and Entrepreneurs Evaluate Intellectual Property?' 50 delegates joined to listen to the discussion and to enjoy some informal networking afterwards. Many thanks to our moderator Edward Rainsford, Appleyard Lees and our expert panellists: Alison McGhee, AstraZeneca; Mike Romanos, Imperial College London; Anne Horgan (nee Nguyen), Cambridge Innovation Capital and Iain Thomas, Cambridge Enterprise.
I am pleased to share…
Our Annual Review is a highly anticipated review of the year including a narrative on One Nucleus services, relevant articles and adverts for the Cambridge Life Science ecosystem as well as our member listing. You can join our influential sponsors by taking out an A4 advert for a great profiling opportunity for your organisation.
The idea of the advert is to showcase your company to our other members and wider network. The recipient profile is similar to the profile for all our activities and membership profile, as illustrated below:
For 2023 we are planning to publish the Annual Review on…
Guest blog by Estelle Roger, Precision for Medicine
Research & Development (R&D) Tax Credits are available to pharma and biotechs to incentivize drug development and clinical research in countries around the world
In this article, we will discuss the United Kingdom’s R&D tax credit program, which is part of its post-Brexit strategy to boost innovation in drug development within its borders. First, a bit of information about Precision for Medicine. We are more than just a Contract Research Organization and have a comprehensive suite of capabilities to support the spectrum…
Guest Blog Post by Sura Hussein, Senior Business Development Manager, London & Partners
Reflecting on the fabulous One Nucleus event last week #Genesis2022 I wanted to share some notes on the panel discussing the key ingredients for a successful Life sciences cluster.
The stage was an upbeat debate with the playful title which was Cambridge UK vs Cambridge MA / USA.
The Debaters were: Catherine Stace, Domainex, Max Bryan, Bidwells, John McCafferty, Maxion Therapeutics, Nick Foster, Metrion Biosciences, Jiahao Huang, Nuclera – chaired by Mike Ward, Clarivate
Taking that I am bias for…
Guest article by RSM UK
There is growing consensus that the UK economy will remain in recession through much of 2023.
We asked our panel of middle market business leaders how prepared they feel for the oncoming difficulties.
Explore the findings
If you would like to submit a guest blog or article, please contact natalie@onenucleus.com
Guest article from RSM UK
The UK's healthcare sector is battling crippling workforce shortages and an unprecedented NHS backlog. Digital innovations will be essential to solving the most pressing health challenges of our generation.
Our healthcare experts examine how harnessing digitalisation and collaboration between the private and public sector can help tackle these key challenges. Read the article
If you are interested in submitting a guest blog or article on the One Nucleus website, please contact natalie@onenucleus.com
Tuesday 1 November
Incredible research needs incredible security in a data-driven, cyber-vulnerable era. The aim of this meeting was to start building a community with an interest in sharing ideas, best practices, and latest developments on cyber security, as well as to bring it on the radar of whole organisations. Ultimately, increased confidence around cyber security policies and procedures is essential to support the science being undertaken and to drive value in our sector. Here are some of the key take-outs from the session:
Nature of Cyber Threats
Cyber risk is one of the most…
Leadership for the Future of Work
Expert insights from Barry Winkless, Cpl’s CSO & Head of the Future of Work Institute Cpl.
The leadership challenge (and opportunity) in the future of work is to purposefully alter an organisation’s genetic make-up and improve it for the better.
I believe that the core DNA of most organisations hasn’t changed that much over the past 30 years - at least until relatively recently. If we were to imagine an archetypal organisation as a colourful DNA strand it would probably have looked at lot like this one (figure 1) with a predominance of blue & orange…
Strong leadership teams within an organisation are essential for employee engagement, satisfaction and overall business performance. With the ‘Anatomy of a Life Science Leader’ panel discussion fast approaching at our annual Genesis conference on 7 December, we’ve been thinking about what you might need to take into consideration when hiring an effective leader. Here are some thoughts…
What is a Good Leader?
First and foremost, having in mind what you believe to be a good leader and defining these traits clearly will help you when creating a job description and throughout the recruitment…
On Tuesday 15 November we had a great evening debating the opportunities and challenges creating Cell and Gene Therapies of tomorrow moderated by Tony Jones, CEO, One Nucleus. Tony was joined on the panel by William Raimes, Head of Process Development, Ori Biotech; Michael Kyriakides, Life Sciences Investor, Synconca; Dirk Werling, Director, Centre for Vaccinology and Regenerative Medicine, Royal Veterinary College and Bams Abila, Visiting Professor (Clinical Pharmacology; Biologics & ATMPs), Kings College London.
The panel discussed…